Lazard Asset Management LLC Neuro Pace Inc Transaction History
Lazard Asset Management LLC
- $61.8 Billion
- Q4 2024
A detailed history of Lazard Asset Management LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Lazard Asset Management LLC holds 3,407 shares of NPCE stock, worth $37,783. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,407
Previous 3,427
0.58%
Holding current value
$37,783
Previous $23,000
65.22%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NPCE
# of Institutions
61Shares Held
21.4MCall Options Held
23.5KPut Options Held
100-
Kck Ltd. Tortola, D85.27MShares$58.5 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$37.8 Million1.03% of portfolio
-
Morgan Stanley New York, NY2.49MShares$27.6 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$27 Million1.9% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.48MShares$16.4 Million7.02% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $276M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...